Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm Invitae has partnered with gene therapy developer Spark Therapeutics to launch a free genetic testing program for patients suspected of having inherited retinal disease (IRD).

In a separate deal, Invitae also partnered with X4 Pharmaceuticals to provide free genetic testing for WHIM syndrome and Severe Congenital Neutropenia (SCN), a group of rare inherited primary immunodeficiencies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.